Evidence map›Paper›PMID 31856942›Full record

Trial reportHealth technology assessment (Winchester, England)2019

Guided self-help for depression in autistic adults: the ADEPT feasibility RCT.

Ailsa Russell, Daisy Gaunt, Kate Cooper, Jeremy Horwood, Stephen Barton, Ian Ensum, Barry Ingham, Jeremy Parr, Chris Metcalfe, Dheeraj Rai and 2 more

Open access · diamondAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Health technology assessment (Winchester, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Ailsa RussellCentre for Applied Autism Research, Department of Psychology, Faculty of Humanities and Social Sciences, University of Bath, Bath, UK.
Daisy GauntBristol Randomised Trials Collaboration, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Kate CooperCentre for Applied Autism Research, Department of Psychology, Faculty of Humanities and Social Sciences, University of Bath, Bath, UK.
Jeremy HorwoodBristol Randomised Trials Collaboration, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Stephen BartonNewcastle Cognitive and Behavioural Therapies Centre, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK.
Ian EnsumBASS Adult Autism Service, Avon & Wiltshire Mental Health Partnership NHS Trust, Bristol, UK.
Barry InghamNorthumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK.
Jeremy ParrInstitute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Chris MetcalfeBristol Randomised Trials Collaboration, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Dheeraj RaiSchool of Social and Community Medicine, Bristol Medical School, University of Bristol, Bristol, UK.
David KesslerSchool of Social and Community Medicine, Bristol Medical School, University of Bristol, Bristol, UK.
Nicola WilesCentre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
University of Bristol · GBCumbria Northumberland Tyne and Wear NHS Foundation Trust · GBUniversity of Bath · GBAvon and Wiltshire Mental Health Partnership NHS Trust · GBNewcastle University · GB

Funding

Department of Health HTA/14/43/02Medical Research Council MR/K025643/1
6 · The paper itself

Abstract

backgroundCo-occurring depression frequently occurs in autism. Evidence-based psychological interventions have been successfully adapted to treat co-occurring anxiety, but there is little evidence about the usefulness of adapted cognitive-behavioural therapy for depression. To the authors' knowledge, to date there have been no randomised trials investigating the usefulness of low-intensity cognitive-behavioural therapy for depression in autism.

objectivesThe objectives of the study were to (1) develop a low-intensity psychological intervention for depression adapted for autism, (2) assess the feasibility and patient and therapist acceptability of the intervention, (3) estimate the rates of recruitment and retention for a full-scale randomised controlled trial and (4) identify an appropriate measure of depression to be used in a full-scale randomised controlled trial.

designThe study comprised a randomised controlled trial (

settingAdult autism services in two NHS regions.

participantsAdults with a diagnosis of autism spectrum disorder with depression, that is, a Patient Health Questionnaire-9 items score of ≥ 10. People who had attended more than six sessions of cognitive-behavioural therapy in the previous 6 months were excluded.

interventionsThe low-intensity intervention (guided self-help) comprised materials for nine individual sessions, based on behavioural activation adapted for autism, facilitated by therapist guides (coaches) who were graduate-level psychologists who attended training and regular supervision. Treatment as usual was standard NHS care for depression.

main outcome measuresOutcomes were measured 10, 16 and 24 weeks post randomisation using self-report and interview measures of depression, anxiety, obsessive-compulsive symptoms, social function and quality of life, and a health-care and service use questionnaire. As this was a feasibility study also designed to identify the most appropriate measure of depression, it was not possible to specify the primary outcome measure or outcome point a priori.

resultsThe aims of the study were met in full. The guided self-help intervention was feasible and well received by participants and coaches. The majority of allocated participants attended the intervention in full. The most practical outcome point was determined to be 16 weeks. There were differential rates of attrition across the treatment groups: 86% of the guided self-help group remained in the study at 24 weeks, compared with 54% of treatment as usual group. The qualitative study suggested that guided self-help had enhanced credibility with participants at the point of randomisation. Inter-rater reliability of the interview measure of depression was less than adequate, limiting the conclusions that can be drawn from the prespecified sensitivity to change analyses.

conclusionsThe intervention was feasible and well received. Although this feasibility study was not a fully powered trial, it provided some evidence that the guided self-help intervention was effective in reducing depressive symptoms. A full-scale clinical effectiveness and cost-effectiveness trial of the intervention is warranted. FUTURE WORK: Improvements to the intervention materials as a result of qualitative interviews. Stakeholder consultation to consider future trial design, consider strategies to improve retention in a treatment as usual arm and select a self-report measure of depression to serve as the primary outcome measure.

trial registrationCurrent Controlled Trials ISRCTN54650760.

fundingThis project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in

Indexed as

Cognitive Behavioral TherapyComorbiditySelf ReportAdultAutistic DisorderBrief Psychiatric Rating ScaleCost-Benefit AnalysisDepressionEnglandFeasibility StudiesFemaleHumansMaleMiddle AgedPatient Acceptance of Health CareReproducibility of ResultsAUTISMCOGNITIVE–BEHAVIOURAL THERAPYDEPRESSIONLOW-INTENSITY INTERVENTIONRANDOMISED CONTROLLED TRIAL

Identifiers

PMID31856942
PMCPMC6943380
OpenAlexW2994656717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.